000 06227nam a22003975i 4500
001 289562
003 MX-SnUAN
005 20160429154714.0
007 cr nn 008mamaa
008 150903s2011 xxu| o |||| 0|eng d
020 _a9781607618577
_99781607618577
024 7 _a10.1007/9781607618577
_2doi
035 _avtls000343390
039 9 _a201509030408
_bVLOAD
_c201405050256
_dVLOAD
_y201402061155
_zstaff
040 _aMX-SnUAN
_bspa
_cMX-SnUAN
_erda
050 4 _aQH573-671
100 1 _aMiyata, Toshio.
_eeditor.
_9319836
245 1 0 _aStudies on Renal Disorders /
_cedited by Toshio Miyata, Kai-Uwe Eckardt, Masaomi Nangaku.
264 1 _aTotowa, NJ :
_bHumana Press,
_c2011.
300 _axviii, 800 páginas 101 ilustraciones, 31 ilustraciones en color.
_brecurso en línea.
336 _atexto
_btxt
_2rdacontent
337 _acomputadora
_bc
_2rdamedia
338 _arecurso en línea
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
_2rda
490 0 _aOxidative Stress in Applied Basic Research and Clinical Practice
500 _aSpringer eBooks
505 0 _aPreface -- Chapter 1. Oxidative stress injury in glomerular mesangium -- Chapter 2. Transition Metals and other Forms of Oxidative Protein Damage in -- Renal Disease -- Chapter 3. Cyclo-oxygenase in the kidney and oxidative stress -- Chapter 4. Renin angiotensin system in the kidney and oxidative stress -Local Renin-Angiotensin-Aldosterone-System and NAD(P)H oxidase-dependent oxidative stress in the kidney- -- Chapter 5. Thiamine in diabetic renal disease – dietary insufficiency, renal -- washout, anti-stress gene response, therapeutic supplements, risk predictor and link to genetic susceptibility -- Chapter 6. Novel members of the globin family and their function against oxidative stress -- Clinical Aspects of Oxidative Stress in the Kidney -- Chapter 7. Hypertension -- Chapter 8. Uric acid and oxidative stress -- Chapter 9. Reactive oxygen and nitrogen species, oxidative and nitrosative -- stress and their role in the pathogenesis of acute kidney injury -- Chapter 10. Oxidative stress in the kidney: proximal tubule disorders -- Chapter 11. Iron metabolism and oxidative stress -- Chapter 12. Hypoxia, oxidative stress and the pathophysiology of contrast-media-induced nephropathy -- Chapter 13. Cardiovascular complications in renal failure: implications of advanced glycation end-products and their receptor, RAGE -- Chapter 14. Infection and the kidney -- Chapter 15. Oxidative/carbonyl stress in the renal circulation and cardiovascular renal injury -- -- Current Therapy Targeting Oxidative Stress -- Chapter 16. Renin angiotensin system -- Chapter 17. Oxidative stress in kidney injury-peroxisome proliferator-activated receptor-? agonists are in control -- Chapter 18. Statin -- Chapter 19. N-acetylcysteine in kidney disease -- Chapter 20. Advanced glycation end products (AGEs) inhibitor -- Section 2. ‘Hypoxia’ -- Hypoxia Biology -- Chapter 21. Involvement of hypoxia-inducible factor 1 in physiological and pathological responses to continuous and intermittent hypoxia: Role of reactive oxygen species -- Chapter 22. Regulation of oxygen homeostasis by PHDs -- Chapter 23. Oxygen-dependent regulation of erythropoiesis -- Chapter 24. Intricate link between hypoxia and oxidative stress in chronic kidney disease -- Chapter 25. RNA interference and the regulation of renal gene expression in -- hypoxia -- Hypoxia Pathology in Renal Disorders -- Chapter 26.Cardio-renal connection: The role of hypoxia and oxidative stress -- Chapter 27. HIF in acute kidney injury – from pathophysiology to a novel approach of organ protection -- Chapter 28. Hypoxia in chronic kidney disease: the final common pathway to end stage renal disease -- Chapter 29. Oxidative stress and hypoxia in the pathogenesis of diabetic -- nephropathy -- Chapter 30. Estimation of kidney oxygenation by BOLD-MRI -- Chapter 31. Anemia and progression of chronic kidney disease -- Section 3. Novel therapeutic approaches against oxidative stress and hypoxia -- Chapter 32. Novel therapeutic approaches against hypoxia and oxidative stress,targeting intracellular sensor molecules for oxygen and oxidative stress -- Chapter 33. Endoplasmic reticulum (ER) stress as a target of therapy against oxidative stress and hypoxia -- Chapter 34. Stem cell therapy against oxidative stress and hypoxia.
520 _aConditions such as oxidative stress and hypoxia, which have a generalized impact on the oxygen metabolism, have been implicated in the genesis of kidney disease. This means that deepening our understanding of the pathobiology of oxygen metabolism in such diseases could be a fruitful path towards tangible clinical benefits. Studies in Renal Disorder collects reviews from leading researchers and clinical scientists working in exactly this field, providing an overview of the latest advances. The causal role of impaired oxygen metabolism in kidney disease has numerous clinical implications. It affects our understanding of the therapeutic benefits accruing from anti-hypertensive agents; the way we control hyperglycemia/hyperinsulinemia and hyperlipidemia; and our use of dietary approaches to the correction of obesity. The defensive mechanisms against oxidative stress, such as the Nrf2-Keap1 system, and hypoxia, such as the PHD-HIF system, have recently been explored in various cells, including kidney cells. These mechanisms include intracellular sensors for oxidative stress and hypoxia. This means that novel approaches targeting these sensors may offer clinical benefits in kidney disease in which oxidative stress and/or hypoxia is a final, common pathway.
590 _aPara consulta fuera de la UANL se requiere clave de acceso remoto.
700 1 _aEckardt, Kai-Uwe.
_eeditor.
_9319837
700 1 _aNangaku, Masaomi.
_eeditor.
_9319838
710 2 _aSpringerLink (Servicio en línea)
_9299170
776 0 8 _iEdición impresa:
_z9781607618560
856 4 0 _uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-1-60761-857-7
_zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL)
942 _c14
999 _c289562
_d289562